KeyBank National Association’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,356	Closed	-$216K	–	1162
2024 Q3	$216K	Buy	+6,356	New	+$216K	﹤0.01%	1071
2023 Q2	–	Sell	-5,810	Closed	-$209K	–	1063
2023 Q1	$209K	Hold	5,810	–	–	﹤0.01%	1005
2022 Q4	$259K	Buy	+5,810	New	+$259K	﹤0.01%	921